Related Experiment Video
Updated: Aug 23, 2026

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid
P F Schuck1, R B Rosa, L F Pettenuzzo
1Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600 Anexo, CEP 90035-003, Porto Alegre, RS, Brazil.
Abstract:
Accumulation of methylmalonic acid (MMA) in tissues and biological fluids is the biochemical hallmark of patients affected by the neurometabolic disorder known as methylmalonic acidemia (MMAemia). Although this disease is predominantly characterized by severe neurological findings, the underlying mechanisms of brain injury are not totally established. In the present study, we investigated the effect of MMA, as well as propionic (PA) and tiglic (TA) acids, whose concentrations are also increased but to a lesser extend in MMAemia, on total (tCK), cytosolic (Cy-CK) and mitochondrial (Mi-CK) creatine kinase (CK) activities from cerebral cortex of 30-day-old Wistar rats. Total CK activity (tCK) was measured in whole cell homogenates, whereas Cy-CK and Mi-CK were determined, respectively, in cytosolic and mitochondrial preparations from rat cerebral cortex. We verified that tCK and Mi-CK activities were significantly inhibited by MMA at concentrations as low as 1 mM, in contrast to Cy-CK which was not affected by the presence of the acid in the incubation medium. Furthermore, PA and TA, at concentrations as high as 5 mM, did not alter CK activity. We also observed that the inhibitions provoked by MMA were fully prevented by pre-incubation of the homogenates with reduced glutathione, suggesting that the inhibitory effect of MMA was possibly mediated by oxidation of essential thiol groups of the enzyme. Considering the importance of CK for brain metabolism homeostasis, our results suggest that inhibition of this enzyme by increased levels of MMA may contribute to the neurodegeneration of patients affected by MMAemia and explain previous reports showing an impairment of brain energy metabolism and a reduction of brain phosphocreatine levels caused by MMA.
Insights
Methylmalonic acid (MMA) accumulation in methylmalonic acidemia (MMAemia) inhibits brain creatine kinase (CK) activity, potentially contributing to neurodegeneration. Other acids did not show this effect.
Area of Science:
- Biochemistry
- Neuroscience
- Metabolic Disorders
Background:
- Methylmalonic acidemia (MMAemia) is a neurometabolic disorder marked by methylmalonic acid (MMA) accumulation.
- Neurological damage is a primary characteristic of MMAemia, but the exact mechanisms remain unclear.
- Creatine kinase (CK) plays a crucial role in maintaining brain energy homeostasis.
Purpose of the Study:
- To investigate the impact of MMA, propionic acid (PA), and tiglic acid (TA) on creatine kinase (CK) activity in the rat cerebral cortex.
- To explore the potential role of MMA-induced CK inhibition in the neurodegeneration observed in MMAemia.
Main Methods:
- Measurement of total (tCK), cytosolic (Cy-CK), and mitochondrial (Mi-CK) creatine kinase activities in Wistar rat cerebral cortex homogenates.
- Incubation of enzyme preparations with varying concentrations of MMA, PA, and TA.
- Assessment of MMA's inhibitory mechanism using reduced glutathione pre-incubation.
Main Results:
- Methylmalonic acid (MMA) significantly inhibited total (tCK) and mitochondrial (Mi-CK) creatine kinase activities at 1 mM.
- Cytosolic (Cy-CK) activity remained unaffected by MMA, while propionic acid (PA) and tiglic acid (TA) showed no inhibitory effects even at 5 mM.
- MMA-induced inhibition was reversed by reduced glutathione, suggesting oxidation of thiol groups on the enzyme.
Conclusions:
- Inhibition of creatine kinase (CK) by elevated methylmalonic acid (MMA) levels may be a key factor in the neurodegeneration associated with methylmalonic acidemia (MMAemia).
- These findings suggest a potential mechanism for impaired brain energy metabolism and reduced phosphocreatine levels observed in MMAemia patients.

